Clincosm LogoSign in Get a demo

Recurrent Ovarian Carcinoma

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Clear Cell Adenocarcinoma

Active, not recruiting
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Anchorage, Alaska
  • +584 more
Jan 28, 2023

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Metastatic Fallopian Tube Carcinoma, Metastatic Ovarian Carcinoma, Metastatic Primary Peritoneal Carcinoma Trial in United

Active, not recruiting
  • Metastatic Fallopian Tube Carcinoma
  • +11 more
  • Phoenix, Arizona
  • +13 more
Dec 2, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Active, not recruiting
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Ipilimumab
  • Nivolumab
  • Auburn, California
  • +205 more
Oct 18, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +44 more
Jan 10, 2022

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Mobile, Alabama
  • +141 more
Jul 22, 2019

Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,

Completed
Has Results
  • Adult Hepatocellular Carcinoma
  • +44 more
  • Scottsdale, Arizona
  • +60 more
Jan 24, 2019

Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma Trial in United States

Completed
Has Results
  • Recurrent Fallopian Tube Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • Rilotumumab
  • Burbank, California
  • +27 more
Aug 8, 2017

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (drug, procedure,

Withdrawn
  • Fallopian Tube Carcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 12, 2017

Primary Peritoneal Carcinoma, Recurrent Ovarian Carcinoma Trial in Philadelphia (Paclitaxel Poliglumex)

Completed
  • Primary Peritoneal Carcinoma
  • Recurrent Ovarian Carcinoma
  • Paclitaxel Poliglumex
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 12, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016